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Abstract
The erythrocytic stage development of malaria parasites occurs within the parasitophorous vacuole inside the infected-
erythrocytes, and requires transport of several parasite-encoded proteins across the parasitophorous vacuole to several
locations, including the cytosol and membrane of the infected cell. These proteins are called exported proteins; and a large
number of such proteins have been predicted for Plasmodium falciparum based on the presence of an N-terminal motif
known as the Plasmodium export element (PEXEL) or vacuolar transport signal (VTS), which has been shown to mediate
export. The majority of exported proteins contain one or more transmembrane domains at the C-terminus and one of three
types of N-terminus domain architectures. (1) The majority, including the knob-associated histidine rich protein (KAHRP),
contain a signal/hydrophobic sequence preceding the PEXEL/VTS motif. (2) Other exported proteins, including the P. berghei
variant antigen family bir and the P. falciparum skeleton binding protein-1, do not appear to contain a PEXEL/VTS motif. (3)
The P. falciparum erythrocyte membrane protein-1 (PfEMP1) family lacks a signal/hydrophobic sequence before the motif.
These different domain architectures suggest the presence of multiple export pathways in malaria parasites. To determine if
export pathways are conserved in plasmodia and to develop an experimental system for studying these processes, we
investigated export of GFP fused with N- and C-terminus putative export domains in the rodent malaria parasite P. berghei.
Export was dependent on specific N- and C-terminal domains. Constructs with a KAHRP-like or bir N-terminus, but not the
PfEMP1 N-terminus, exported GFP into the erythrocyte. The C-terminus of a P. falciparum variant antigen rifin prevented GFP
export by the KAHRP-like N-terminus. In contrast, GFP chimeras containing KAHRP-like N-termini and the PfEMP1 C-terminus
were exported to the surface of erythrocytes. Taken together, these results suggest that proteins with KAHRP-like
architecture follow a common export pathway, but that PfEMP1s utilize an alternative pathway. Functional validation of
common putative export domains of malaria parasites in P. berghei provides an alternative and simpler system to
investigate export mechanisms.
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Introduction
The development of erythrocytic malaria parasites is accompa-
nied by transport of parasite-encoded proteins beyond the
parasitophorous vacuole membrane (PVM) to multiple locations,
including the cytoplasm and membrane of the infected-erythro-
cyte. These proteins confer remarkably altered properties to
infected erythrocytes, including increased permeability to a variety
of substances, increased rigidity, and adherence to endothelial cells
[1]. A key family of P. falciparum exported proteins is collectively
termed P. falciparum erythrocyte membrane protein-1 (PfEMP1).
These proteins are transported to the surface of erythrocytes to
mediate cytoadherence to vascular endothelial cells, a key
pathogenic mechanism of P. falciparum [2]. Members of the
PfEMP1family are diverse in sequence, and only one member is
predominantly expressed in a given developmental cycle, thus
allowing antigenic variation to evade the host immune response
[3]. PfEMP1 is anchored on the surface of parasitized erythrocytes
in electron dense knobs through interactions with erythrocyte
cytoskeleton proteins and parasite encoded proteins, including the
knob-associated histidine-rich protein (KAHRP) [2]. Some other
characterized exported proteins include rifins and stevors, two
other variant antigen families of unknown function [4,5,6],
skeleton binding protein-1 (SBP1) [7], ring-exported protein-2
(REX2) [8], and surfins [9]. SBP1 and RXP2 are associated with
the Maurer’s cleft [7,8], and SBP1 also plays a key role in the
transport of PfEMP1 [10,11]. Surfins are polymorphic antigens
localized to the PVM and the surface of infected erythrocytes, and
have unknown function [9]. Other malaria parasites also have
rifin-like variant antigen proteins, including the bir protein family
in P. berghei [12].
A five amino acid sequence (RxLxQ/E) termed the Plasmodium
Export Element (PEXEL) or Vacuolar Targeting Signal (VTS) has
been identified in the amino terminus of the majority of known
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PEXEL/VTS motif of several exported proteins, including
PfEMP1, have been shown to export GFP in P. falciparum-infected
erythrocytes [13,14]. Also, the PEXEL/VTS motifs of some
predicted exported proteins of P. vivax and P. gallinaceum exported
GFP in P. falciparum-infected erythrocytes [13]. Bioinformatic
analyses identified several proteins with PEXEL/VTS motifs in
multiple Plasmodium species, including the mouse model parasite P.
berghei [15]. The PEXEL motif has been shown to be processed in
the endoplasmic reticulum, and this cleavage appears to be a
prerequisite for export because mutations in this motif abrogate
both processing and export of PEXEL-containing proteins
[16,17]. Recently, plasmepsin V, an endoplasmic reticulum
resident aspartic protease, has been shown to process the PEXEL
motif [18,19]. Additionally, a proposed translocon for protein
export has been recently discovered in the parasitophorous
vacuole membrane (PVM) of P. falciparum [20].
Several exported proteins, including SBP1, surfins, and the P.
berghei variant antigen family bir lack the PEXEL/VTS motif [21],
and export signals for such proteins have not been identified. The
majority of exported proteins contain one or more transmembrane
domains at the C-terminus, and share three types of N-terminus
domain architectures [21]. (1) The N-termini of the majority of
exported proteins (here termed Type 1), including KAHRP, rifins,
and stevors, contain a hydrophobic/signal sequence preceding the
PEXEL/VTS motif. (2) Several other known exported proteins
(Type 2), including SBP-1, REX2 and bir proteins do not contain
the PEXEL/VTS motif. (3) Lastly, PfEMP1 proteins do not have a
signal/hydrophobic sequence before the PEXEL/VTS (Type 3).
Several type-1 N-termini, including that of KAHRP, which
contains a signal/hydrophobic sequence followed by the PEXEL/
VTS motif, have been shown to be sufficient for export of reporter
proteins into the P. falciparum-infected erythrocyte [13,14]. For
Type-2 proteins like SBP1 and RXP2, both N and C-termini have
been shown to be required for export [8,22]. For PfEMP1s, which
represent Type 3 proteins, different lengths of the N-terminus
together with the C-terminus appear to be required for export
[13,14,23].
Different domain architectures of plasmodial exported proteins
suggest multiple export pathways in malaria parasites [24].
Characterization of these export pathways may facilitate the
identification of novel drug or vaccine targets. As the rodent
parasite P. berghei offers a simple animal model and much more
efficient genetic manipulation than P. falciparum [25,26], it may
facilitate characterization of plasmodial protein export, especially
since it was recently shown that a PEXEL/VTS motif allowed
GFP export into the P. berghei-infected erythrocyte [27]. To
determine if malaria parasites have evolved multiple mechanisms
for exporting different types of proteins, we transfected P. berghei
with plasmids expressing GFP fused with portions of a number of
exported proteins representing the three domain architectures
described above and evaluated transport of chimeras in infected
erythrocytes.
Results
Construction of GFP chimeras
To determine if malaria parasites have evolved a single or
multiple mechanisms for exporting proteins with different domain
architecturesand toidentifyfunctionallyconservedexportelements,
we constructed GFP chimeras containing N-termini of proteins
representing the three domain architectures of plasmodial exported
proteins (Fig. 1). Representative Type 1 proteins, which include the
majority of exported proteins with a signal/hydrophobic sequence
preceding the PEXEL/VTS motif, were KAHRP (PFB0100c), rifin
(PFA0745w),stevor (PFC1105w), and a predicted P. berghei exported
protein (PB402722.00.0). The Type 2 proteins, in which the
PEXEL/VTS motif is absent, were represented by a bir protein.
The Type 3 domain architecture, which lacks a signal/hydrophobic
sequence before the PEXEL/VTS motif, was represented by a
PfEMP1 protein (PFD1235w). Additionally, to determine the effect
of the C-terminus on export, GFP chimeras containing the C-
termini of PfEMP1, rifin, and bir were constructed (Fig. 1). GFP
chimeras were transfected into P. berghei using the plasmid pSTCII-
GFP (Fig. 1), and live infected-erythrocytes were examined using an
epifluorescencemicroscope todetermine whetherGFPwas retained
in the parasite or exported to the infected erythrocyte.
N-termini with a signal/hydrophobic sequence preceding
the PEXEL/VTS motif exported GFP
To investigate if the PEXEL/VTS motif is functional in P.
berghei, parasites were transfected with plasmids encoding GFP
chimeras containing the N-terminus of PfEMP1 (PfEMP1-GFP),
KAHRP (KHARP-GFP) and a predicted P. berghei exported
protein (Pb-GFP); and the localization of GFP was examined in
live infected cells. KAHRP-GFP and Pb-GFP expressing cells
showed fluorescence in the erythrocyte cytosol, indicating that
GFP was exported into erythrocytes (Fig. 2A). In PfEMP1-GFP
expressing cells GFP was confined to the parasite cytosol,
indicating that GFP was not exported into erythrocytes (Fig. 2A).
Thus, the PEXEL/VTS motif is functional in P. berghei, mediating
transport to the erythrocyte, but the motif functions only with an
upstream signal/hydrophobic sequence.
PEXEL/VTS motif independent export is present in
P. berghei
To determine if a PEXEL/VTS independent export pathway is
present in P. berghei, a GFP reporter containing a flag-tagged bir
protein sequence (PB200037.00.0) at the N-terminus (FBir-GFP)
was expressed in P. berghei. The FBir-GFP expressing cells showed
fluorescence in the erythrocyte (Fig. 2B), indicating that GFP was
exported, and thus providing evidence that a PEXEL/VTS
independent pathway for transport from the parasite is conserved
in Plasmodia.
The C-terminus of rifin prevented export of GFP
To determine if C-terminal regions of exported proteins affect
export mediated by their cognate N-termini, GFP chimeras
containing the C-terminus of rifin and the N-terminus of the same
rifin protein (Rifin-GFP-RCter), the N-terminus of PfEMP1
(PfEMP1-GFP-RCter), or the N-terminus of KAHRP (KHARP-
GFP-RCter) were expressed. As expected, since the PfEMP1 N-
terminus did not export GFP, the PfEMP1-GFP-RCter protein
was not transported into the erythrocyte (Fig. 3A). However,
surprisingly, the C-terminus of rifin prevented GFP transport into
the erythrocyte by the N-termini of KAHRP and rifin (Fig. 3A).
To rule out the possibility that the C-terminus of rifin included in
these reporter proteins lacked additional sequence necessary for
export, a reporter containing the entire rifin sequence with
GFP inserted between N-terminal amino acids 51–52 (Rifin-GFP-
R52-336) was expressed in parasites. In parallel, another construct
with the same length N-terminus of rifin followed by GFP and the
bir sequence (Rifin-GFP-Bir) was also expressed in parasites. Rifin-
GFP-R52-336 was not exported whereas Rifin-GFP-Bir was
exported into the erythrocyte (Fig. 3B). Thus, at least in this case,
the C-terminus of exported proteins carries destination specific
information.
Protein Export in P. berghei
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The C-terminus of PfEMP1contains a transmembrane domain
and a cytosolic domain designated the acidic terminal segment. To
determine if these domains are required together with the
PEXEL/VTS motif for the export of PfEMP1, GFP chimeras of
the PfEMP1 N-terminus together with the transmembrane
domain (PfEMP1-GFP-TM) or the entire C-terminus (PfEMP1-
GFP-Cter) were expressed in parasites. Both PfEMP1-GFP-TM
and PfEMP1-GFP-Cter expressing parasites showed fluorescence
confined to the parasite; thus the PfEMP1 C-terminus region did
not mediate transport to the erythrocyte (Fig. 4A). However, GFP
chimeras containing the KAHRP N-terminus and the transmem-
brane domain (KHARP-GFP-TM) or the C-terminus (KHARP-
GFP-Cter) of PfEMP1 were transported into the infected
erythrocyte (Fig. 4A). Similarly, GFP chimeras containing the
PfEMP1 C-terminus and the N-termini of rifin (Rifin-GFP-Cter),
stevor (Stevor-GFP-Cter), and the predicted P. berghei exported
protein (Pb-GFP-Cter) were transported into the erythrocyte
(Fig. 4B). Thus, the N-termini of KAHRP, rifin, and stevor are
functional in P. berghei, and the export process appears to be
unaffected by the PfEMP1 C-terminus. In contrast, the PfEMP1
N-terminus alone or together with its C-terminus does not mediate
export in P. berghei.
Export of GFP to the erythrocyte surface
Parasite-encoded proteins that are present on the surface of
infected erythrocytes, notably PfEMP1family proteins, play key
roles in immune evasion and pathogenesis [3,28]. However, in
Figure 1. Schematics of exported proteins and transfection plasmid. (A) The three major types of architectures seen among exported
proteins are shown with amino acid numbers indicated. The Type 1 proteins, represented by KAHRP, rifin, stevor, and a predicted P. berghei exported
protein, contain a signal/hydrophobic sequence preceding the PEXEL/VTS motif. The Type 2 proteins, represented by the P. berghei variant antigen
bir, lack the PEXEL/VTS motif. The Type 3 proteins, including the PfEMP1 family, lack a signal/hydrophobic sequence before the PEXEL/VTS motif. (B)
The transfection plasmid pSTCII-GFP expresses GFP under the control of the P. yoelii chloroquine resistance transporter (PyCRT 59) upstream and the
P. vivax actin (PvAc 39) downstream untranslated regions. It has pGEM backbone for replication in E. coli, and the pyrimethamine resistant Toxoplasma
gondii dihydrofolate reductase-thymidylate synthase gene (TgDHFR-TS) under the control of the P. yoelii a tubulin (PyaTb 59) upstream and the P.
vivax a tubulin (PvaTb 39) downstream untranslated regions for selection of transfected parasites. (C) Schematic of GFP reporter constructs utilized in
this report showing different regions of exported proteins. GFP is green and the remainder of the color scheme is as defined in panel A.
doi:10.1371/journal.pone.0010227.g001
Figure 2. N-termini with a signal/hydrophobic sequence preceding the PEXEL/VTS motif exported GFP. (A) GFP reporters with the N-
terminus of PfEMP1 (PfEMP1-GFP), KAHRP (KAHRP-GFP), and a predicted P. berghei exported protein (Pb-GFP) were expressed in P. berghei, and live
parasites were stained with the DNA labeling dye Hoechst and viewed under an epifluorescence microscope. The expression of GFP, staining of the
parasite nucleus (Hoechst), bright field images, and merged images are shown for representative trophozoite-stage parasites. (B) A GFP chimera of a
flag-tagged P. berghei variant antigen bir (Fbir-GFP), which lacks the PEXEL/VTS motif, was expressed in P. berghei, and live trophozoite-stage
parasites were imaged as described above.
doi:10.1371/journal.pone.0010227.g002
Protein Export in P. berghei
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possible for several reasons, including the lack of easily available
animal models. Identification of export elements mediating
transport of PfEMP1 to the surface of P. berghei-infected
erythrocytes may allow studies on PfEMP1-associated virulence
in mice. Therefore, parasites expressing GFP chimeras of the
PfEMP1 C-terminus and N-termini of KAHRP (KAHRP-GFP-
Cter), rifin (Rifin-GFP-Cter), stevor (Stevor-GFP-Cter), the
predicted P. berghei exported protein (Pb-GFP-Cter), and PfEMP1
(PfEMP1-GFP-Cter) were analyzed for the presence of GFP on the
erythrocyte surface. These chimeras contained a TEV protease
recognition site at the junction of GFP and the PfEMP1 C-
terminus. As live cells are not permeable to TEV protease,
treatment of live parasites with TEV protease would cleave GFP
only if it is present on the surface of infected erythrocytes. Parasites
expressing the GFP chimeras were treated with TEV protease,
reaction supernatants were immunoprecipitated, and precipitated
proteins were detected using anti-GFP antibodies. Expected sizes
of products were detected in immunoprepitates from protease-
treated KAHRP-GFP-Cter, Rifin-GFP-Cter, Stevor-GFP-Cter,
and Pb-GFP-Cter, but not from PfEMP1-GFP-Cter and untreated
parasites (Fig. 5). These data indicate that GFP is present on the
surface of KAHRP-GFP-Cter, Rifin-GFP-Cter, Stevor-GFP-Cter,
and Pb-GFP-Cter infected erythrocytes, and thus these N-termini
together with the C-terminus of PfEMP1 mediate expression of
PfEMP1 on the surface of P. berghei-infected erythrocytes.
Discussion
The majority of known and predicted plasmodial exported
proteins contain one or more transmembrane domains in their C-
termini and one of three types of N-terminus domain architec-
tures. The most common architecture, referred to here as Type 1,
includes a hydrophobic/signal sequence preceding the PEXEL/
VTS motif (KAHRP, rifin, stevor and the P. berghei putative
exported protein (PB402722.00.0)). In Type 2 exported proteins,
such as bir and SBP1, N-termini do not contain the PEXEL/VTS
motif. Type 3 architecture is seen in PfEMP1 proteins, which lack
a signal/hydrophobic sequence before the PEXEL/VTS motif.
To determine if export of these three types of proteins utilizes a
Figure 3. The C-terminus of rifin prevented GFP export. Trophozoite-stage parasites were imaged as described for Fig. 2. (A) Parasites
expressing GFP chimeras containing the C-terminus of rifin at the carboxy terminus and the N-terminus of PfEMP1 (PfEMP1-GFP-RCter), rifin (Rifin-
GFP-RCter) or KAHRP (KAHRP-GFP-RCter) at the N-terminus. (B) Parasites expressing GFP chimeras with the N-terminus of rifin upstream and the
remaining region of rifin (Rifin-GFP-R52-336) or a bir protein (Rifin-GFP-Bir) downstream.
doi:10.1371/journal.pone.0010227.g003
Protein Export in P. berghei
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efficient experimental system for studying protein export, we
investigated export of GFP fused with the N- and C-terminus
regions of proteins representing each type of domain architecture
in the rodent parasite P. berghei. Of note, P. berghei allows much
easier and more efficient transfection than does the human
pathogen P. falciparum. Considering export signals from the N-
terminus, Type 1 and Type 2 N-termini exported GFP into
erythrocytes. However, the Type 3 N-terminus did not export
GFP. Considering signals from the C-terminus, the C-terminus of
rifin prevented GFP export by Type 1 N-termini, whereas the C-
terminus of PfEMP1 allowed GFP export of the same N-termini to
the surface of infected erythrocytes. These results suggest that the
majority of exported plasmodial proteins, which have a Type 1 N-
terminus, utilize a common export pathway, but that PfEMP1
export differs from this common pathway. Additionally, these
Figure 4. The C-terminus of PfEMP1 did not affect GFP export. Trophozoite-stage parasites were imaged as described for Fig. 2. (A) Parasites
expressing GFP chimeras containing the N-terminus of PfEMP1 or KAHRP and the transmembrane domain or the C-terminus of PfEMP1 (PfEMP1-GFP-
TM, KAHRP-GFP-TM, PfEMP1-GFP-Cter, KAHRP-GFP-Cter). (B) Parasites expressing GFP chimeras containing the C-terminus of PfEMP1 at the carboxy-
terminus and N-terminus of rifin (Rifin-GFP-Cter), stevor (Stevor-GFP-Cter), and a predicted P. berghei exported protein (Pb-GFP-Cter) at the N-
terminus were imaged.
doi:10.1371/journal.pone.0010227.g004
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export from the parasite, the final destination of exported proteins
is guided by the C-terminus.
Export of GFP into P. berghei-infected erythrocytes by Type 1 N-
termini of both P. falciparum and P. berghei exported proteins
suggests the presence of a common export pathway in Plasmodia.
Our results are consistent with a recently published study
demonstrating export of GFP in P. berghei-infected erythrocytes
by the N-terminus of P. falciparum histidine rich protein II, which
has a Type 1 N terminus [27]. Although it has been suggested that
bir proteins are also exported, the localization of these proteins in
the infected erythrocyte has not previously been shown [12]. Our
data showing export of GFP by a bir protein indicates that, as
predicted, bir proteins are exported into the infected erythrocyte.
Furthermore, export of GFP by a bir protein, which lacks a
PEXEL/VTS motif, indicates that a PEXEL/VTS-independent
mode of export is present in P. berghei. Although it is yet to be
determined if bir or other Type 2 proteins also contain a signature
export sequence analogous to the PEXEL/VTS motif in Type 1
proteins, recently published studies of the Type 2 proteins SBP1
and ring-exported protein-2 (REX2) revealed that 30 and 10
amino acid stretches of the N-termini of SBP1 and REX2,
respectively, together with their C-terminus transmembrane and
cytosolic domains are required for export in P. falciparum [8,22].
The N-termini of SBP1 and REX2 do not appear to have a
common motif, but both have a net negative charge; this feature
has been proposed as a requirement for the export of SBP1 [22].
Interestingly, the first 40 amino acids of the N-terminus of the bir
protein studied herein also has a net negative charge, suggesting
that PEXEL/VTS-independent export employs a common
mechanism in malaria parasites. The presence of a common
export mechanism in malaria parasites is also supported by
conservation of the components of a recently discovered transport
complex in the parasitophorous vacuole membrane (PVM) of P.
falciparum, which has been proposed to be required for protein
export [20]. However, further studies are needed to determine if
the PEXEL/VTS-independent export mechanism in P. berghei is
similar to that present in P. falciparum.
PfEMP1 export is of particular interest because it is commonly
associated with the virulence of P. falciparum. An in vivo system to
study PfEMP1-associated pathogenesis is not available. The
identification and functional validation of PfEMP1 export
elements in P. berghei may lead to a system for expression of
PfEMP1 on the surface of P. berghei-infected erythrocytes, which
may be used for in vivo studies of cytoadherence. We, therefore,
investigated transport of GFP chimeras containing N- and C-
terminus regions of PfEMP1 in P. berghei. The N-terminus of
PfEMP1 alone and together with its transmembrane domain or C-
terminus did not export GFP in P. berghei-infected erythrocytes,
suggesting that PfEMP1 export employs a mechanism different
from that of Type 1 exported proteins. This mechanism may be
unique to P. falciparum, which expresses a family of ,60 PfEMP1
proteins [29]. The PfEMP1 used in this study has been localized to
the surface of P. falciparum-infected erythrocytes, and has a well
defined PEXEL/VTS motif (RNILE) [30]; N-termini of other
PfEMP1s containing analogous sequences have been shown to
export GFP in P. falciparum-infected erythrocytes [13,14,23].
Interestingly, another study found that a PEXEL/VTS sequence
present further downstream in the first Duffy Binding Like (DBL)
domain was required for export of a PfEMP1 into P. falciparum-
infected erythrocytes [14]. As large proteins like PfEMP1 may
have several PEXEL/VTS like motifs, it has not been definitively
shown if PEXEL/VTS alone or other motifs are required for
export of PfEMP1. Additionally, as PfEMP1 export has been
shown to require several accessory proteins, including SBP1, the
absence of SBP1 and some other proteins in P. berghei could
explain the inability of the PfEMP1 regions to mediate export of
GFP. Furthermore, knock out of SBP1 blocked export of PfEMP1
but not export of proteins with Type 1 and Type 2 architectures
[10,11]. These results further support the presence of a specific
export mechanism for PfEMP1 in P. falciparum.
The majority of exported plasmodial proteins have one or more
transmembrane domains in their C-termini, but the roles of these
domains in the export process are not yet known. Considering that
C-termini of proteins are often involved in targeting and
anchoring at the target site, export of GFP fused to the rifin and
PfEMP1 C-termini was investigated. The C-terminus of rifin, but
not that of PfEMP1, prevented GFP export by Type 1 N-termini,
including the N-terminus of the same rifin protein. This result was
surprising, because the C-terminus of a different rifin protein did
not prevent GFP export by its N-terminus in another study in P.
falciparum [13]. Interestingly, a recent study demonstrated that
there are two types of rifins: A and B [31,32]. The A-type rifins are
exported into the infected erythrocyte whereas B-type rifins are
not exported [31]. The rifin studied herein is B-type, whereas the
rifin that did not prevent GFP export in P. falciparum was A-type
[13]. Thus, inhibition of GFP export by the C-terminus of rifin in
our study is in agreement with the intraparasitic localization of B-
type rifins in P. falciparum, and this result suggests that C-termini of
exported proteins determine their destination. This study further
suggests that the PEXEL/VTS motif transports proteins across the
PVM and that the C-terminus then plays a key role in transport to
Figure 5. Export of GFP to the erythrocyte surface. Live
trophozoite-infected erythrocytes expressing GFP reporter proteins
with the PfEMP1 C-terminus at the carboxy terminus and the N-
terminus of PfEMP1 (PfEMP1-GFP-Cter), KAHRP (KAHRP-GFP-Cter),
stevor (Stevor-GFP-Cter), a predicted P. berghei exported protein (Pb-
GFP-Cter), or rifin (Rifin-GFP-Cter) were incubated with (+) or without
(2) TEV protease. Digestion samples were centrifuged, and superna-
tants were immunoprecipitated with protein-A agarose-coupled rabbit
anti-GFP antibodies. The immunoprecipitates were processed for
western blotting. The predicted sizes of full-length proteins in each
case are .85 kDa and of the TEV cleaved products <30 kDa (36 kDa for
PfEMP1-GFP-Cter). The presence of signal at <30 kDa in protease-
containing samples indicates export of GFP to the surface of infected
erythrocytes. The larger band (<60 kDa) is likely due to cross reactivity
of secondary antibodies with the heavy chain of rabbit anti-GFP
antibodies used for immunoprecipitation. No larger signals indicating
the presence of unprocessed proteins were seen.
doi:10.1371/journal.pone.0010227.g005
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proteins with known destinations, is required to better understand
the role of the C-terminus in determining the destination of
export.
We demonstrated that GFP chimeras with Type 1 N-termini
and the PfEMP1 C-terminus were exported to the surface of
infected erythrocytes. This result provides proof of concept toward
generation of transgenic P. berghei parasites expressing defined
regions of PfEMP1 as a tool for in vivo studies of PfEMP1-
associated pathogenesis. In fact, a similar reporter protein of GFP
fused with the N-terminus of KAHRP and the C-terminus of
PfEMP1 has been shown to export GFP to the surface of P.
falciparum-infected erythrocytes [23]. Thus, this result suggests that
even though PfEMP1 export is only present in P. falciparum, Type 1
N-termini with appropriate C-terminus regions may be used to
transport proteins to desired locations in P. berghei.
In summary, we have characterized diverse signals for the
export of proteins by P. berghei. Export was mediated in P. berghei by
N-termini with a signal/hydrophobic sequence followed by the
PEXEL/VTS motif (Type 1) and a bir protein that lacks a
PEXEL/VTS motif (Type 2), but not by the N-terminus of
PfEMP1, which lacks a signal/hydrophobic sequence before its
PEXEL/VTS motif (Type 3). Thus, multiple export mechanisms
appear to be present in malaria parasites. While the majority of
proteins with a signal/hydrophobic sequence preceding the
PEXEL/VTS motif may utilize a common export mechanism,
the export of PfEMP1 appears to employ an alternative
mechanism, which may be unique to P. falciparum. In addition,
some proteins are exported without a PEXEL/VTS motif.
However, it is possible that these three types of exported proteins
utilize different pathways only for initial aspects of export with
convergence to a common pathway. Functional validation of
common putative export domains of malaria parasites in P. berghei
provides an alternative and simpler system compared to P.
falciparum to investigate export mechanisms. In addition, our data
demonstrating export of GFP to the surface of P. berghei-infected
erythrocytes may pave the way for generation of an expression
system to display desired proteins, particularly defined cytoadher-
ence regions of PfEMP1, on the surface of P. berghei-infected
erythrocytes. This system might be used for in vivo studies of
cytoadherence mediated by different PfEMP1 molecules.
Materials and Methods
Plasmid construction
We constructed the pSTCII transfection plasmid to express
GFP reporter proteins in P. berghei. The pSTCII-GFP plasmid
expresses GFP under the control of the upstream untranslated
region of the P. yoelii chloroquine resistance transporter (PyCRT
59) gene and downstream untranslated region of the P. vivax actin
(PvAc 39) gene. It has a pGEM backbone for replication in E. coli,
and encodes the pyrimethamine resistant Toxoplasma gondii
dihydrofolate reductase-thymidylate synthase gene (TgDHFR-
TS) under the control of the P. yoelii a tubulin gene (PyaTb 59)
upstream untranslated region and the P. vivax a tubulin (PvaTb 39)
downstream untranslated region to allow selection of transfected
parasites in P. berghei. The multiple cloning site contains Bgl II-
Kpn I sites, a penta-alanine linker (Ala5), GFP followed by a penta-
glycine (Gly5) linker, a Tobacco etch virus (TEV) protease cleavage
site, and Bam HI-Xho I sites. To construct pSTCII-GFP, PyCRT
59 (1.245 kb, primers: 5PyCRTF/5PyCRTR) and PyaTb 59
(1.203 kb, primers: 5Py aTb1F/5PyaTb1R) were amplified from
P. yoelii genomic DNA; PvAc 39 (0.551 kb) (primers: 3UT Act F1/
3UT ActR1) and PvaTb 39 (0.566 kb) (primers: 3UT TbF1/3UT
TbR1) were amplified from P. vivax genomic DNA; and the left
and right flanks of the P. berghei C-small subunit ribosomal RNA
(SSU) were amplified from P. berghei genomic DNA (primers:
CSSUF/CSSULR; right flank: CSSURF/CSSURR) (see Table
S1 for all primer sequences). The CSSULR and CSSURF primers
were complementary (39 of the left flank and 59 of the right flank
were overlapping), which allowed PCR-mediated recombination
of left and right flanks with CSSUF and CSSURR primers to
produce the CSSUL/R fragment (1.035 kb) containing central
Avr II and Pac I sites. To mutate internal Age I, Xho I, and Bgl II
sites of the pyrimethamine resistant Toxoplasma gondii dihydrofolate
reductase-thymidylate synthase gene (TgDHFR-TS, 1.846 kb), the
ORF was amplified in three fragments (TgDTA: F1/R1; TgDTB:
F2/R2; F3/R3) using Phusion DNA polymerase and primers
containing one base silent mutations corresponding to the
restriction enzyme sites. The 59 and 39 ends of TgDTB were
overlapping with the 39 end of TgDTA and the 59 end of TgDTC,
respectively. These fragments were recombined into the mutated
TgDHFR-TS gene (TgDTsm) with F1 and R3 primers using
PCR. 39-A overhangs were added to TgDHFR-TS using Taq
DNA polymerase and deoxynucleotides at 70uC for 30 min, the
tailed-product was cloned into the pGEM-T vector (Promega) to
construct pGT-TgDTsm, and the product was sequenced to
confirm desired sequence. The GFP coding sequence was
amplified from the pSSPF2/HspGFP plasmid [33] using a mixture
of Taq and Vent DNA polymerases with forward (GFPbsc F) and
reverse (GFPbsc R) primers, to produce GFPbsc. 39-A overhangs
were added to GFPbsc using Taq DNA polymerase, the tailed-
product was cloned into the pGEM-T vector (Promega) to
construct pGT-GFPbsc, and the product was sequenced to
confirm desired sequence. The pGEM backbone was excised
from pHTK [34] by digesting with Nar I- Not I, and pGEM and
the components described above were assembled into the pSTCII-
GFP plasmid through several cloning and subcloning steps.
Reporter constructs
Primers corresponding to N-termini of PfEMP1 (PFD1235w; 92
amino acids), KAHRP (PFB0100c; 70 amino acids), a predicted P.
berghei exported protein (PB402722.00.0; Pb, 71 amino acids) and a
bir protein (PB200037.00.0; FBir, flag tag +294 amino acid bir
sequence) were used to PCR amplify the corresponding sequences
from P. falciparum genomic DNA or cDNA or P. berghei genomic
DNA using Phusion DNA polymerase (New England Biolabs). 59-
and 39-A overhangs were added to these fragments, and they were
cloned into the pGEM-T vector, sequenced, and excised with Bgl
II-Kpn I. The Bgl II-Kpn I digested N-termini were cloned into
similarly digested pSTCII-GFP to construct pSTCII-PfEMP1-
GFP, pSTCII- KAHRP-GFP, pSTCII- Pb-GFP, and pSTCII-
FBir-GFP plasmids. Primers used were: PfEMP1: NTSF/NTSR;
KAHRP: K70F/K70R; Pb: PBpredF/PBpredR; FBir: BirF1/
BirR1).
To construct pSTCII- PfEMP1-GFP-TM and pSTCII-
KAHRP-GFP-TM plasmids, a 66 amino acid coding sequence
of PfEMP1 (PFD1235w), including the 24 amino acid transmem-
brane region, was amplified from P. falciparum cDNA (TMATSF/
TMATSR2). 59- and 39-A overhangs were added, and fragments
were cloned into pGEM-T, sequenced, excised with Bam HI-Xho
I, and cloned into similarly digested pSTCII- PfEMP1-GFP and
pSTCII- KAHRP-GFP plasmids to construct the pSTCII-
PfEMP1-GFP-TM and pSTCII- KAHRP-GFP-TM plasmids,
respectively. The 454 amino acid C-terminus region (Cter) of
PfEMP1 (PFD1235w) containing the transmembrane and cyto-
solic domains of PfEMP1 was amplified from P. falciparum cDNA
(TMATSF/TMATSR1), mutated to remove the internal Kpn I
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overhangs, cloned into pGEM-T, and sequenced. The Cter
fragment was excised with BamH I-Xho I, and cloned into
similarly digested pSTCII-PfEMP1-GFP and pSTCII- KAHRP-
GFP to obtain pSTCII-PfEMP1-GFP-Cter and pSTCII-
KAHRP-GFP-Cter, respectively.
To construct reporter plasmids containing N-termini of a rifin
(PFA0745w), a stevor (PFC1105w), and a predicted P. berghei
exported protein (PB402722.00.0, Pb), corresponding regions of
these genes were amplified from P. falciparum cDNA or P. berghei
genomic DNA using Phusion DNA polymerase and primers (Rifin:
51 aa, RifF/RifR; Stevor: 63 aa, SteF/SteR; Pb, 71 amino acids,
PBpredF/PBpredR). These PCR products were tailed with A-
overhangs as described above, cloned into pGEM-T, and
sequenced. These fragments were excised with Bgl II-Kpn I and
cloned into similarly digested pSTCII-PfEMP1-GFP-Cter replac-
ing the Cter, and yielding pSTCII-rifin-GFP-Cter, pSTCII-stevor-
GFP-Cter, and pSTCII-Pb-GFP-Cter plasmids.
The C-terminus regions of rifin were amplified from P.
falciparum cDNA using Phusion DNA polymerase and primers
(RCter, 78 aa: TMrifF/TMrifR; R52-336, 285 amino acids:
TMRifF1/TMrifR). The pSTCII- PfEMP1-GFP-TM, pSTCII-
KAHRP-GFP-TM, and pSTCII-rifin-GFP-Cter plasmids were
digested with Bam HI-Xho I to excise the PfEMP1 transmem-
brane and C-terminus regions, and the plasmid backbones were
ligated with a similarly digested RCter fragment to obtain
pSTCII- PfEMP1-GFP- RCter, pSTCII- KAHRP-GFP- RCter,
and pSTCII-rifin-GFP- RCter, respectively. Similarly, pSTCII-
rifin-GFP-Cter was digested with Bam HI-Xho I to excise the
PfEMP1 Cter, and the plasmid backbone was ligated with
similarly digested R52-336 to obtain pSTCII-rifin-GFP- R52-336
plasmid. For the pSTCII-Rifin-GFP-Bir plasmid, bir protein
coding sequence was amplified from P. berghei genomic DNA using
Phusion DNA polymerase and primers BirF2/BirR2; the PCR
fragment was digested with Bam HI-Xho I, and it was cloned into
the plasmid backbone of similarly digested pSTCII-rifin-GFP-Cter
replacing the PfEMP1 Cter.
Parasite culture and isolation of genomic DNA and RNA
Studies with experimental animals were approved by the
University of California, San Francisco Animal Care and Use
Committee, and followed guidelines of this committee and the
United States Department of Agriculture. P. falciparum 3D7 strain
was cultured in RPMI1640 supplemented with 10% human serum
[35]. Parasite-infected erythrocytes were harvested at 10–15%
parasitemia. After centrifugation, the supernatant was aspirated
off, and the pellet was treated with 0.1% saponin for 5 min in ice
to lyse erythrocytes, and then centrifuged at 10000 rpm for 5 min.
The supernatant was discarded, the pellet was washed twice with
cold PBS to remove erythrocyte membranes, and parasites were
recovered by centrifugation at 10000 rpm for 5 min. The
supernatant was discarded, and the parasite pellet was processed
for genomic DNA and RNA isolation using the PUREGENE
TM
DNA isolation kit (Gentra SYSTEMS) and Trizol method
(Invitrogen), respectively. cDNA was produced from 5–10 mg
genomic DNA-free RNA using the SuperScript First-Strand
Synthesis System for RT-PCR (Invitrogen).
P. berghei ANKA strain (MRA-311) was obtained from Malaria
Research and Reagent Reference Resource Center (MR4). A
frozen stock was thawed at room temperature, injected into two 7–
10 week old female Balb/c mice intraperitoneally with a 22G
needle, and infection was monitored from day 3 onwards by
making smears from tail vein snips. At <20% parasitemia, mice
were euthanized and blood was collected by cardiac puncture in
10 ml Alsevier’s solution. Blood was passed through the
LeukoLOK filter (Ambion) to remove leukocytes and centrifuged
at 2000 rpm for 5 min, supernatant was aspirated off, and the
pellet containing parasite-infected red blood cells was processed for
transfection or isolation of genomic DNA. For genomic DNA
isolation, blood was processed as described above.
Transfection
Transfection experiments were performed according to pub-
lished protocols using the Nucleofector Device II and the human
T-Cell Nucleofector kit (Amaxa) [36]. Briefly, the erythrocyte
pellet containing P. berghei-infected cells was suspended in
RPMI1640 (supplemented with 20% heat-inactivated fetal bovine
serum) at 0.5–1% haematocrit in a sterile 250 ml plastic
Erlenmeyer flask (Corning). The culture was gassed (5% CO2,
2% O2, and 93% N2) and incubated at 37uC at 85 rpm until the
majority of parasites matured to schizonts. To purify schizont
stage parasites, the parasite suspension was layered under a 55%
Nycodenz gradient (Invitrogen) and centrifuged at 1000 rpm for
10 min in a swing bucket centrifuge without using brakes;
interphase and top layers containing schizonts and free merozoites
were collected and centrifuged at 3000 rpm for 5 min. The
supernatant was discarded and the parasite pellet was washed
twice with PBS, and parasites were used for 4–5 transfection
experiments. For each experiment, parasites were mixed with
100 ml Nucleofector solution containing 5–10 mg transfection
construct and electroporated using the U33 program of the
Nucleofector Device II. The electroporated sample was immedi-
ately injected into the tail vein of a Balb/c mouse using a 30G
needle. For selection of transfected parasites, mice were given
pyrimethamine intraperitoneally (1.25 mg/100 ml of 50%
DMSO/day) or in drinking water (70 mg/l H2O, pH 5.0) 24 hour
post-electroporation and thereafter. Infection was monitored by
making smears from tail snips every other day beginning on day 5.
When parasitemia was .5%, mice were euthanized, and blood
was collected as described above. 100–150 ml of the infected blood
(diluted with PBS to 1% parasitemia) was injected intraperitonially
into a naı ¨ve mouse for second round selection with pyrimethamine
in drinking water. The remainder of the blood was centrifuged at
2000 rpm for 5 min, supernatant was aspirated off, and pellet was
suspended in 2X volume of glycerolyte and stored at 280uC
overnight followed by long term storage in liquid N2.
Imaging of live parasites
5–10 ml blood was collected in 1 ml Alseviers’ solution from the
tail vein of a second round-selection mouse, the blood was
centrifuged at 2000 rpm for 5 min, the supernatant was aspirated
off, and the pellet was suspended in 3 ml RPMI1640 (supple-
mented with 20% FBS), and transferred to a 50 ml sterile tube.
The tube was gassed and incubated at 37uC for 8–10 hrs to obtain
trophozoite and schizont stages. 1 ml of the culture was
transferred to a 1.5 ml microfuge tube, the tube was centrifuged
at 14000 rpm for 10 seconds, the supernatant was aspirated off,
and the pellet was washed twice with PBS and suspended in 1 ml
PBS. Hoechst dye was added to the parasite suspension (1 mg/ml),
and a 300–500 ml suspension was layered on a wet poly L-lysine
coated glass slide (Sigma). The slide was incubated at room
temperature for 10–15 min in a wet chamber (covered with
aluminium foil), and unattached cells were washed off gently with
PBS. A 20640 mm glass coverslip (Sigma) was placed over the
cells, and parasites were imaged under a 1006objective lens using
a Zeiss Axioplan epifluorescence microscope. Images were
captured using a Hamamatsu CCD camera, and processed using
Openlab software (Improvision).
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immunoblotting
To determine surface localization of GFP, second round-
selection parasites (expressing KHARP-GFP-Cter, Rifin-GFP-
Cter, Stevor-GFP-Cter, Pb-GFP-Cter, and PfEMP1-GFP-Cter)
were collected by cardiac puncture of euthanized mice as
described above. Blood was passed through the LeukoLOK filter
(Ambion) to remove leukocytes and centrifuged at 2000 rpm for
5 min, supernatant was aspirated off, and the pellet containing
parasite-infected red blood cells was suspended in RPMI 1640
(supplemented with 20% heat inactivated fetal bovine serum) at
0.5–1% haematocrit in a sterile 250 ml plastic Erlenmeyer flask
(Corning). The culture was gassed (5% CO2,2 %O 2, and 93% N2)
and incubated at 37uC at 85 rpm for 6–8 hours to obtain
trophozoites. The culture was then centrifuged at 2000 rpm for
5 min; the supernatant was aspirated off and the pellet (300–
380 ml packed cell volume of red blood cells with 8–10%
parasitemia) was suspended in PBS and divided into two equal
aliquots. The aliquots were centrifuged at 2000 rpm for 5 min,
supernatants were aspirated off, and each pellet was suspended in
500 ml RPMI1640 containing 0.5 mM EDTA, 1 mM DTT, 0.1%
BSA. 1.5 ml (15 U) of TEV protease (Invitrogen) was added to one
aliquot, and an equal volume of the TEV protease storage buffer
(50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 5 mM DTT, 50%
glycerol, 0.1% Triton X-100 (final Triton X-100 concentration
0.0003%)) was added to another aliquot. Both samples were
incubated at room temperature for 90 min with gentle shaking,
and then centrifuged at 14000 rpm for 2 min. The supernatants
were transferred to 1.5 ml microfuge tubes. The volume of each
supernatant was adjusted to 1 ml with PBS, including 30 mlo f
protein-A-agarose slurry (Pharmacia), 5 ml rabbit anti-GFP
antibodies (Invitrogen), and 100 ml 10% BSA, and then incubated
at 4uC overnight with gentle shaking. Each supernatant was passed
through a spin column on a 2 ml microfuge tube; the flowthrough
was discarded and the protein-A-agarose resin with immunopre-
cipate was washed twice with A1 buffer (50 mM Tris-Cl, pH 7.5,
150 mM NaCl, 1 mM EDTA, 0.1% NP40). The column
containing the resin was placed on a 1.5 ml microfuge tube,
40 ml 1 x SDS-PAGE sample buffer was added directly over the
resin, the sample was incubated at 95–100uC for 5 min, and it was
then centrifuged at 14000 rpm for 2 min. Column flow throughs
(<30 ml) containing immunoprecipitates were run on a 12% SDS-
PAGE gel and transferred onto the nitrocellulose membrane. The
membrane was blocked with 3% nonfat dry milk in PBS-0.05%
Tween-20, incubated with mouse anti-GFP antibodies (Invitrogen,
Cat No. A1121) at 1/1000 dilution in the blocking buffer for 1 hr
at room temperature, and then incubated with HRP-conjugated
goat light chain-specific anti-mouse IgG (1/5000 in blocking
buffer) for 1 hr at room temperature. The signal was developed
with the SuperSignal Western Blotting kit (Pierce) on X-ray film
(GE Healthcare).
Supporting Information
Table S1 Primers used in the study.
Found at: doi:10.1371/journal.pone.0010227.s001 (0.05 MB
DOC)
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